WBA Stock Recent News

News that Walgreens Boots Alliance quarterly loss was better than expected and pharmacy sales are rising bodes well for a financial turnaround under new private equity ownership.

Walgreens is reportedly seeing an uptick in sales as it prepares to go private. [contact-form-7] The company released quarterly earnings Thursday (June 26) showing sales of $39 billion, a 7.2% increase from the same quarter last year, driven by growth in its American retail pharmacy and international segments.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday.

Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A) posted better-than-expected earnings for the fiscal second quarter, driven by stronger pharmacy sales, international growth and cost controls. Sales increased 7.2% from the year-ago quarter to $38.99 billion, ahead of estimates of $36.59 billion.

CNBC's Jim Cramer breaks down why he's keeping an eye on shares of Walgreens.

While the top- and bottom-line numbers for Walgreens (WBA) give a sense of how the business performed in the quarter ended May 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

WBA tops Q3 earnings and sales estimates and lifts shares, but the gross margin contracts, and guidance is withdrawn.

Walgreens Boots Alliance (WBA) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.63 per share a year ago.

Walgreens Boots Alliance Thursday reported a narrower-than-expected $178 million loss in its third quarter as the struggling pharmacy chain nears the end of its long run as a publicly traded company.

Walgreens previously said it was withdrawing its fiscal-year outlook after reaching a take-private deal with Sycamore Partners.